KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹25 Cr | ₹-2.39 Cr | ₹-1.91 Cr | ₹-1.24 Cr | ₹-0.90 Cr |
What is the latest Total Non-Current Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹-2.39 Cr |
| Mar2023 | ₹-1.91 Cr |
| Mar2022 | ₹-1.24 Cr |
| Mar2021 | ₹-0.90 Cr |
How is Total Non-Current Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | Positive | |
| Mar2024 | ₹-2.39 Cr | Negative | |
| Mar2023 | ₹-1.91 Cr | Negative | |
| Mar2022 | ₹-1.24 Cr | Negative | |
| Mar2021 | ₹-0.90 Cr | - | |
Compare Total Non-Current Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹620.2 Cr | -5.1% | -8.8% | -25.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -5.1% |
-8.8% |
-25.4% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses